← Evidence map

ArticleAllergy2021

Dupilumab is effective in type 2-high asthma patients receiving high-dose inhaled corticosteroids at baseline.

Arnaud Bourdin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 33010038